DFN-11

Phase 2Completed

0 views this week 0 watching💤 Quiet

Interest: 32/100

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

Phase 2

Phase 3

Approved

Indication / Disease

Rapidly Escalating Migraine

Conditions

Rapidly Escalating Migraine

Trial Timeline

Sep 1, 2015 → May 1, 2016

NCT ID

NCT02571049

About DFN-11

DFN-11 is a phase 2 stage product being developed by Dr. Reddy's Laboratories for Rapidly Escalating Migraine. The current trial status is completed. This product is registered under clinical trial identifier NCT02571049. Target conditions include Rapidly Escalating Migraine.

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (2)

NCT ID	Phase	Status	Start	Completion	Indication
NCT02569853	Phase 3	Completed	Sep 21, 2015	Feb 26, 2018	Episodic Migraine
NCT02571049	Phase 2	Completed	Sep 1, 2015	May 1, 2016	Rapidly Escalating Migraine